Neochromosome and Opentrons Introduce Automated Antibody Discovery Solution, Enabling Labs to Achieve Rapid, Cost-Effective In-House Development
Platform integrates yeast-based synthetic biology and robotics to streamline antibody discovery, eliminating lengthy steps and significantly reducing costs compared to traditional CRO outsourcing LONG ISLAND CITY, N.Y.–April 29, 2025– Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, and Neochromosome, Inc., its… Read More